View of Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review

Return to Article Details Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review Download Download PDF